Earnouts are a staple of life sciences M&A. They bridge valuation gaps, allocate regulatory risk, and align incentives around post-closing development. But they also generate some of the most...
On March 2025, a sweeping reform of the Delaware General Corporation Law (DGCL) took effect. SB 21 codifies safe harbors...
Controversial rulings—combined with high-profile criticism from high profile figures like Elon Musk—have sparked a broader debate about whether companies...
The Delaware Chancery Court has ruled office supply company Essendant Inc. must face a lawsuit after it bailed out...
Categories
